Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5

Mammalian Genome

Volumn 23, Issue 3-4, 2012, Pages 277-285

  Amlin Van Schaick, Jessica ^a,b   Kim, Sungjin ^c   Broman, Karl W ^c   Reilly, Karlyne M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CANCER RESISTANCE; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC RISK; LINKAGE ANALYSIS; MALE; MODIFIER GENE; MOUSE; NONHUMAN; SPINAL CORD CANCER; SPINAL CORD RESISTANCE TO ASTROCYTOMA MODIFIER 1 GENE; TUMOR LOCALIZATION;

ANIMALS; ASTROCYTOMA; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; DISEASE MODELS, ANIMAL; FEMALE; GENES, MODIFIER; HUMANS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; SPINAL CORD;

MUS;

EID: 84862658938     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-011-9380-0     Document Type: Article

References (31)

1. Bailey JS, Grabowski-Boase L, Steffy BM, Wiltshire T, Churchill GA, Tarantino LM (2008) Identification of quantitative trait loci for locomotor activation and anxiety using closely related inbred strains. Genes Brain Behav 7:761-769
2. Benes V 3rd, Barsa P, Benes V Jr, Suchomel P (2009) Prognostic factors in intramedullary astrocytomas: a literature review. Eur Spine J 18:1397-1422
3. Binder BR, Mihaly J (2008) The plasminogen activator inhibitor "paradox" in cancer. Immunol Lett 118:116-124
4. Broman KW, Wu H, Sen S, Churchill GA (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19:889-890
5. Calzolari F, Malatesta P (2010) Recent insights into PDGF-induced gliomagenesis. Brain Pathol 20:527-538
6. Cao Y, Lathia JD, Eyler CE, Wu Q, Li Z, Wang H, McLendon RE, Hjelmeland AB, Rich JN (2010) Erythropoietin receptor signaling through STAT3 is required for glioma stem cell maintenance. Genes Cancer 1:50-61
7. Caplan J, Pradilla G, Hdeib A, Tyler BM, Legnani FG, Bagley CA, Brem H, Jallo G (2006) A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization. Neurosurgery 59:193-200 discussion 193-200
8. Chastre E, Abdessamad M, Kruglov A, Bruyneel E, Bracke M, Di Gioia Y, Beckerle MC, van Roy F, Kotelevets L (2009) TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness. FASEB J 23:916-928
9. Chen TC, Hinton DR, Zidovetzki R, Hofman FM (1998) Upregulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab Invest 78:165-174
10. Ellis JA, Canoll P, McCormick PC 2nd, Feldstein NA, Anderson RC, Angevine PD, Kaiser MG, McCormick PC, Bruce JN, Ogden AT (2011) Platelet-derived growth factor receptor (PDGFR) expression in primary spinal cord gliomas. J Neurooncol. doi:10.1007/s11060-011-0666-6
11. Han X, Stewart JE Jr, Bellis SL, Benveniste EN, Ding Q, Tachibana K, Grammer JR, Gladson CL (2001) TGF-beta1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate. Oncogene 20:7976-7986
12. Harrop JS, Ganju A, Groff M, Bilsky M (2009) Primary intramedullary tumors of the spinal cord. Spine (Phila Pa 1976) 34:S69-S77
13. Hitoshi Y, Harris BT, Liu H, Popko B, Israel MA (2008) Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord. Cancer Res 68:8507-8515
14. Hsu S, Quattrone M, Ostrom Q, Ryken TC, Sloan AE, Barnholtz-Sloan JS (2011) Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study. J Neurosurg Spine 14:742-747
15. Huang CH, Yang WH, Chang SY, Tai SK, Tzeng CH, Kao JY, Wu KJ, Yang MH (2009) Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia 11:1371-1382
16. Kawa S, Fujimoto J, Tezuka T, Nakazawa T, Yamamoto T (2004) Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling. Genes Cells 9:219-232
17. Lucci-Cordisco E, Zito I, Gensini F, Genuardi M (2003) Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A 122A:325-334
18. Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA (2010) Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study. J Neurooncol 98:83-92
19. Mock BA, Krall MM, Dosik JK (1993) Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc Natl Acad Sci USA 90:9499-9503
20. Mohyeldin A, Dalgard CL, Lu H, McFate T, Tait AS, Patel VC, Wong K, Rushing E, Roy S, Acs G, Verma A (2007) Survival and invasiveness of astrocytomas promoted by erythropoietin. J Neurosurg 106:338-350
21. Noren NK, Pasquale EB (2007) Paradoxes of the EphB4 receptor in cancer. Cancer Res 67:3994-3997
22. Peres EA, Valable S, Guillamo JS, Marteau L, Bernaudin JF, Roussel S, Lechapt-Zalcman E, Bernaudin M, Petit E (2011) Targeting the erythropoietin receptor on glioma cells reduces tumour growth. Exp Cell Res 317(16):2321-2332
23. Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T (2000) Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet 26:109-113
24. Reilly KM, Tuskan RG, Christy E, Loisel DA, Ledger J, Bronson RT, Smith CD, Tsang S, Munroe DJ, Jacks T (2004) Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci USA 101:13008-13013
25. Ridley AJ (2006) Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16:522-529
26. Sharma S, Free A, Mei Y, Peiper SC, Wang Z, Cowell JK (2010) Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH. Exp Mol Pathol 89:169-174
27. Smith R, Sheppard K, DiPetrillo K, Churchill G (2009) Quantitative trait locus analysis using J/qtl. Methods Mol Biol 573:175-188
28. Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King MC, Egilsson V, Devilee P, McManus R et al (1994) Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 7:103-107
29. Walrath JC, Fox K, Truffer E, Gregory AlvordW, Quinones OA, Reilly KM (2009) Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin- specific manner. Mamm Genome 20:214-223
30. Wang Y, Yao M, Zhou C, Dong D, Jiang Y, Wei G, Cui X (2010) Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle. Neuroscience 167:750-757
31. Zhang K, Kagan D, DuBois W, Robinson R, Bliskovsky V, Vass WC, Zhang S, Mock BA (2009) Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. Blood 114:2952-2960